Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ's Fasenra approved in Europe as an add-on for severe eosinophilic asthma

pharmafileJanuary 12, 2018

Tag: AZ , eosinophilic asthma

PharmaSources Customer Service